StockData
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31

AC Immune SA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026
$2.44+0.04 (+1.88%)

Close on Oct 19, 2026

Ownership

Who owns AC Immune's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
1 buys · 2 sales
Net sold $27.90K

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Affiris AG in Liqu6,428,1006.50%13G (passive) amendmentDec 13, 2024
BVF Inc.19,522,43619.70%13G (passive) amendmentSep 30, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Martin ZuegelInterim CEO, Director71,4080.07%Jun 15, 2026
Andrea PfeiferChief Executive Officer, Director3,834,2883.77%May 18, 2026
Piergiorgio DonatiChief Operating Officer141,1200.14%Mar 20, 2026
Christopher James RobertsChief Financial Officer155,3820.15%Mar 18, 2026
Carl Howard JuneDirector67,5560.07%Jun 15, 2026
Roy Ervin TwymanDirector92,5560.09%Jun 15, 2026
Monika BuetlerDirector71,6560.07%Jun 15, 2026
Renee Aguiar-LucanderDirector51,1360.05%Jun 15, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Monika Buetler
Director
Jun 11, 2026Award+17,751––71,656
Martin Zuegel
Interim CEO, Director
Jun 11, 2026Award+33,136––71,408
Renee Aguiar-Lucander
Director
Jun 11, 2026Award+16,568––51,136
Carl Howard June
Director
Jun 11, 2026Award+16,568––67,556
Roy Ervin Twyman
Director
Jun 11, 2026Award+16,568––92,556
Andrea Pfeifer
Chief Executive Officer, Director
May 15, 2026Sale(10b5-1 plan)−10,000$2.79$27.90K3,820,288
Andrea Pfeifer
Chief Executive Officer, Director
Apr 15, 2026Sale(10b5-1 plan)−10,000$3.14$31.40K3,830,288
Andrea Pfeifer
Chief Executive Officer, Director
Apr 15, 2026Buy−10,000$3.14$31.40K3,830,288

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
M.A Pfeifer Andrea
Director, Officer
May 15, 202620,000$56.00KMay 15, 2026Previously Exercised Stock Options
M.A Pfeifer Andrea
Officer
Apr 15, 202610,000$31.90KApr 15, 2026Previously Exercised Stock Options
M.A Pfeifer Andrea
Officer
Jan 15, 202630,000$110.10KJan 15, 2026Previously Exercised Stock Options
M.A Pfeifer Andrea
Officer
Oct 3, 202545,000$140.85KOct 3, 2025Previously Exercised Stock Options
M.A Pfeifer Andrea
Officer
Sep 12, 202535,000$83.30KSep 12, 2025Previously Exercised Stock Options
M.A Pfeifer Andrea
Officer
Jul 24, 202520,000$46.80KJul 24, 2025Previously Exercised Stock Options
M. A. Pfeifer Andrea
Officer
Sep 27, 202440,000$148.00KSep 27, 2024Previously Exercised Stock Options
M. A. Pfeifer Andrea
Officer
Sep 18, 202420,000$69.20KSep 18, 2024Previously Exercised Stock Options
AG in Liqu AFFIRIS
10% Stockholder
May 16, 2024150,000$499.50KMay 16, 2024Merger/acquisition
Pfeifer Andrea
Officer
Dec 28, 202394,000$467.18KDec 28, 2023Ex Opt C comm shs
Pfeifer Andrea
Officer
Dec 15, 202395,000$352.45KDec 15, 2023Series B Pref. shares
Pfeifer Andrea
Officer
Dec 11, 202320,000$73.80KDec 11, 2023Series B Pref. shares
Pfeifer Andrea
Officer
Dec 6, 202320,000$70.00KDec 6, 2023Series B Pref. shares
Pfeifer Andrea
Officer
Aug 22, 202316,990$52.33KAug 22, 2023Series B Pref. shares
Pfeifer Andrea
Officer
Aug 21, 20231,509$4.60KAug 21, 2023Series B Pref. shares